AMBISOME(R) - PHARMACOKINETICS AND CLINICAL-RESULTS

被引:0
作者
HEINEMANN, V [1 ]
JEHN, U [1 ]
SCHOLZ, P [1 ]
GLEIXNER, B [1 ]
MOHRLE, W [1 ]
WACHHOLZ, K [1 ]
KOLB, HJ [1 ]
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT INTERNAL MED 2,W-8000 MUNICH 70,GERMANY
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S147 / S148
页数:2
相关论文
共 5 条
[1]   A PHARMACOLOGIC GUIDE TO CLINICAL USE OF AMPHOTERICIN B [J].
BINDSCHADLER, DD ;
BENNETT, JE .
JOURNAL OF INFECTIOUS DISEASES, 1969, 120 (04) :427-+
[2]   A REVIEW OF COMPLICATIONS OF AMPHOTERICIN-B THERAPY - RECOMMENDATIONS FOR PREVENTION AND MANAGEMENT [J].
MADDUX, MS ;
BARRIERE, SL .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (03) :177-181
[3]   LIPOSOMAL AMPHOTERICIN-B (AMBISOME) - SAFETY DATA FROM A PHASE-II/III CLINICAL-TRIAL [J].
MEUNIER, F ;
PRENTICE, HG ;
RINGDEN, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :83-91
[4]   PHARMACOLOGY AND TOXICOLOGY OF A LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN RODENTS [J].
PROFFITT, RT ;
SATORIUS, A ;
CHIANG, SM ;
SULLIVAN, L ;
ADLERMOORE, JP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :49-61
[5]   EFFICACY OF AMPHOTERICIN-B ENCAPSULATED IN LIPOSOMES (AMBISOME) IN THE TREATMENT OF INVASIVE FUNGAL-INFECTIONS IN IMMUNOCOMPROMISED PATIENTS [J].
RINGDEN, O ;
MEUNIER, F ;
TOLLEMAR, J ;
RICCI, P ;
TURA, S ;
KUSE, E ;
VIVIANI, MA ;
GORIN, NC ;
KLASTERSKY, J ;
FENAUX, P ;
PRENTICE, HG ;
KSIONSKI, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :73-82